1,046
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae

, , ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 1377-1385 | Published online: 12 May 2020

References

  • Alizadeh N, Rezaee MA, Kafil HS, et al. Detection of carbapenem-resistant Enterobacteriaceae by chromogenic screening media. J Microbiol Methods. 2018;153:40–44. doi:10.1016/j.mimet.2018.09.00130189222
  • Lutgring JD, Limbago BM. The problem of carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae detection. J Clin Microbiol. 2016;54(3):529–534. doi:10.1128/JCM.02771-1526739152
  • Durante-Mangoni E, Andini R, Zampino R. Management of carbapenem-resistant Enterobacteriaceae infections. J Clin Microbiol. 2019;25:943–950.
  • Sekar R, Srivani S, Kalyanaraman N, et al. NDM and other mechanisms of carbapenemases among Enterobacteriaceae in rural South India. J Glob Antimicrob Resist. 2019;18:207–214. doi:10.1016/j.jgar.2019.05.02831181271
  • Guh AY, Limbago BM, Kallen AJ. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States. Expert Rev Anti-Infect Ther. 2014;12(5):565–580. doi:10.1586/14787210.2014.90230624666262
  • Bradley N, Lee Y. Practical implications of new antibiotic agents for the treatment of carbapenem-resistant Enterobacteriaceae. Microbiol Insights. 2019;12:1178636119840367. doi:10.1177/117863611984036730992668
  • Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60–67. doi:10.1093/cid/cir20221653305
  • Eichenberger EM, Thaden JT. Epidemiology and mechanisms of resistance of extensively drug resistant Gram-negative bacteria. Antibiotics. 2019;8(2):37. doi:10.3390/antibiotics8020037
  • Sheu -C-C, Chang Y-T, Lin S-Y, Chen Y-H, Hsueh P-R. Infections caused by carbapenem-resistant enterobacteriaceae: an update on therapeutic options. Front Microbiol. 2019;10. doi:10.3389/fmicb.2019.00080
  • Greissl C, Saleh A, Hamprecht A. Rapid detection of OXA-48-like, KPC, NDM, and VIM carbapenemases in Enterobacterales by a new multiplex immunochromatographic test. Eur J Clin Microbiol Infect Dis. 2019;38(2):331–335. doi:10.1007/s10096-018-3432-230448931
  • Girlich D, Grosperrin V, Naas T, Dortet L. CHROMagar™ ESBL/mSuperCARBA bi-plate medium for detection of ESBL-and carbapenemase-producing Enterobacteriaceae from spiked stools. Diagn Microbiol Infect Dis. 2019;95(2):107–112. doi:10.1016/j.diagmicrobio.2019.05.00231171396
  • Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci. 2018;6(1):1.
  • Sadeghi MR, Ghotaslou R, Akhi MT, Asgharzadeh M, Hasani A. Molecular characterization of extended-spectrum β-lactamase, plasmid-mediated AmpC cephalosporinase and carbapenemase genes among Enterobacteriaceae isolates in five medical centres of East and West Azerbaijan, Iran. J Med Microbiol. 2016;65(11):1322–1331. doi:10.1099/jmm.0.00035627655293
  • Shahcheraghi F, Aslani MM, Mahmoudi H, et al. Molecular study of carbapenemase genes in clinical isolates of Enterobacteriaceae resistant to carbapenems and determining their clonal relationship using pulsed-field gel electrophoresis. J Med Microbiol. 2017;66(5):570–576. doi:10.1099/jmm.0.00046728485708
  • Solgi H, Badmasti F, Aminzadeh Z, et al. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla NDM-7 and bla OXA-48. Eur J Clin Microbiol Infect Dis. 2017;36(11):2127–2135. doi:10.1007/s10096-017-3035-328639165
  • Wayne P; Clinical and Laboratory Standards Institute. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; 2019:21
  • Rodríguez-Martínez J-M, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53(11):4783–4788. doi:10.1128/AAC.00574-0919738025
  • Dupont H, Gaillot O, Goetgheluck A-S, et al. Molecular characterization of carbapenem-nonsusceptible enterobacterial isolates collected during a prospective interregional survey in France and susceptibility to the novel ceftazidime-avibactam and aztreonam-avibactam combinations. Antimicrob Agents Chemother. 2016;60(1):215–221. doi:10.1128/AAC.01559-1526482307
  • CLSI C. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. M100-S24 January; 2014.
  • Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):1503. doi:10.3201/eid1809.12035522932472
  • Akhi MT, Ghotaslou R, Alizadeh N, Beheshtirouy S, Memar MY. High frequency of MRSA in surgical site infections and elevated vancomycin MIC. Wound Med. 2017;17:7–10. doi:10.1016/j.wndm.2017.01.002
  • Candan ED, Aksöz N. Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. Acta Biochimica Polonica. 2015;62:4. doi:10.18388/abp.2015_1148
  • Wasfi R, Elkhatib WF, Ashour HM. Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals. Sci Rep. 2016;6:38929. doi:10.1038/srep3892928004732
  • Teethaisong Y, Nakouti I, Evans K, Eumkeb G, Hobbs G. Nitro-Carba test, a novel and simple chromogenic phenotypic method for rapid screening of carbapenemase-producing Enterobacteriaceae. J Glob Antimicrob Resist. 2019;18:22–25. doi:10.1016/j.jgar.2019.01.01230668995
  • Correa AAF, Fortaleza CMCB. Incidence and predictors of health care–associated infections among patients colonized with carbapenem-resistant Enterobacteriaceae. Am J Infect Control. 2019;47(2):213–216. doi:10.1016/j.ajic.2018.08.00730279017
  • Hsueh P-R, Jean -S-S, Lee N-Y, Tang H-J, Lu M-C. Carbapenem-resistant Enterobacteriaceae infections: Taiwan aspects. Front Microbiol. 2018;9:2888. doi:10.3389/fmicb.2018.0288830538692
  • Livorsi DJ, Chorazy ML, Schweizer ML, et al. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States. Antimicrob Resist Infect Control. 2018;7(1):55. doi:10.1186/s13756-018-0346-929719718
  • Mosavian M, Koraei D. Molecular detection of IMP carbapenemase-producing gram-negative bacteria isolated from clinical specimens in Ahvaz, Iran. JJHR. 2016;7(6).
  • Saeed NK, Alkhawaja S, Azam NFAEM, Alaradi K, Al-Biltagi M. Epidemiology of carbapenem-resistant Enterobacteriaceae in a Tertiary Care Center in the Kingdom of Bahrain. J Lab Physicians. 2019;11(2):111. doi:10.4103/JLP.JLP_101_1831160848
  • Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics. 2002;109(1):34–39. doi:10.1542/peds.109.1.3411773539
  • Gao B, Li X, Yang F, et al. Molecular epidemiology and risk factors of ventilator-associated pneumonia infection caused by carbapenem-resistant enterobacteriaceae. Front Pharmacol. 2019;10:262. doi:10.3389/fphar.2019.0026230967778
  • Park JW, Lee H, Park SY, Kim TH. Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea. Antimicrob Resist Infect Control. 2019;8:48. doi:10.1186/s13756-019-0497-330873279
  • Freire MP, de Oliveira Garcia D, Cury AP, et al. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin-and carbapenem-resistant Enterobacteriaceae. Eur J Clin Microbiol Infect Dis. 2019;38(4):755–765. doi:10.1007/s10096-019-03468-430680569
  • Chen C-W, Tang H-J, Chen -C-C, et al. The microbiological characteristics of carbapenem-resistant enterobacteriaceae carrying the mcr-1 gene. J Clin Med. 2019;8(2):261. doi:10.3390/jcm8020261
  • Hu F, Chen S, Xu X, et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China. J Med Microbiol. 2012;61(1):132–136. doi:10.1099/jmm.0.036483-021903823
  • Leclercq R, Cantón R, Brown DF, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013;19(2):141–160. doi:10.1111/j.1469-0691.2011.03703.x22117544
  • Bhaskar BH, Mulki SS, Joshi S, Adhikary R, Venkatesh BM. Molecular characterization of extended spectrum β-lactamase and carbapenemase producing klebsiella pneumoniae from a tertiary care hospital. Indian J Crit Care Med. 2019;23(2):61–66. doi:10.5005/jp-journals-10071-2311831086448
  • Kazemian H, Heidari H, Ghanavati R, et al. Phenotypic and genotypic characterization of ESBL-, AmpC-, and carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates. Med Princ Pract. 2019;28(6):547–551. doi:10.1159/00050031130995662
  • Hertz FB, Jansaker F, Okon KO, et al. ESBL-production in Escherichia coli and Klebsiella pneumoniae isolates from Nigeria. Microbiol Open. 2019;8:e816.
  • Majewski P, Wieczorek P, Ojdana D, et al. Altered outer membrane transcriptome balance with AmpC overexpression in carbapenem-resistant enterobacter cloacae. Front Microbiol. 2016;7:2054. doi:10.3389/fmicb.2016.0205428066375
  • Ranjbar R, Kelishadrokhi AF, Chehelgerdi M. Molecular characterization, serotypes and phenotypic and genotypic evaluation of antibiotic resistance of the Klebsiella pneumoniae strains isolated from different types of hospital-acquired infections. Infect Drug Resist. 2019;12:603. doi:10.2147/IDR.S19963931114256
  • Kim SY, Shin J, Shin SY, Ko KS. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea. Diagn Microbiol Infect Dis. 2013;76(4):486–490. doi:10.1016/j.diagmicrobio.2013.04.00623688521
  • Osei Sekyere J, Amoako DG. Carbonyl cyanide m-chlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant Enterobacteriaceae. Front Microbiol. 2017;8:228. doi:10.3389/fmicb.2017.0022828261184
  • Elawady B, Ghobashy M, Balbaa A. Rapidec Carba NP for detection of carbapenemase-producing enterobacteriaceae in clinical isolates: a cross-sectional study. Surg Infect. 2019;20(8):672–676. doi:10.1089/sur.2019.084
  • Garg A, Garg J, Kumar S, Bhattacharya A, Agarwal S, Upadhyay GC. Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria. Indian J Med Res. 2019;149(2):285–289. doi:10.4103/ijmr.IJMR_36_1831219096
  • Girlich D, Bouihat N, Poirel L, Benouda A, Nordmann P. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco. Clin Microbiol Infect. 2014;20(4):350–354. doi:10.1111/1469-0691.1232523927757
  • Sonnevend A, Ghazawi AA, Hashmey R, et al. Characterization of carbapenem-resistant Enterobacteriaceae with high rate of autochthonous transmission in the Arabian Peninsula. PLoS One. 2015;10(6):e0131372. doi:10.1371/journal.pone.013137226110660
  • Shibl A, Al-Agamy M, Memish Z, Senok A, Khader SA, Assiri A. The emergence of OXA-48-and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. Int J Infect Dis. 2013;17(12):e1130–e1133. doi:10.1016/j.ijid.2013.06.01624021566
  • Cakirlar FK, Gonullu N, Kalayci F, Kiraz N. Detection of carbapenemase genes OXA-48, VIM, IMP, KPC and NDM in carbapenemase-producing klebsiella pneumoniae isolates from blood cultures of hospitalized patients in Istanbul, Turkey. Int J Infect Dis. 2016;45:99. doi:10.1016/j.ijid.2016.02.259